Stay updated on Zoetis Press Releases

Sign up to get notified when there's something new on the Zoetis Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Zoetis Press Releases page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Adds a new press release entry about the FDA EUA for Simparica Trio to treat New World screwworm in dogs and puppies, illustrating expanded veterinary solutions and regulatory progress; accompanying navigation changes reconfigure access to site sections.
    Difference
    2%
    Check dated 2026-08-20T13:46:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new press release reports UK approval of Portela (relfovetmab injection), a long-acting NGF monoclonal antibody for feline osteoarthritis, approved for easing OA pain with a three-month dosing interval in Leatherhead, UK. This expands Zoetis’ portfolio in the UK market and updates the press releases page with the latest regulatory milestone.
    Difference
    0.9%
    Check dated 2026-08-06T09:40:50.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page gains a new press release entry announcing Portela (relfovetmab) launch in Canada and the European Union, highlighting Portela as the first long-acting anti-NGF monoclonal antibody therapy for cats with up to three months of OA pain relief from a single injection. The entry is titled 'Zoetis Launches Portela® (relfovetmab) in Canada and the European Union' and dated July 22, 2026.
    Difference
    0.9%
    Check dated 2026-07-23T05:46:25.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Two new press releases were added: Zoetis announced its agreement to acquire VitalRADS to expand its Global Diagnostics capabilities with teleradiology, imaging services, and workflow technology. The second release reports the Lenivia (izenivetmab) launch in Canada and the European Union for canine osteoarthritis pain management.
    Difference
    2%
    Check dated 2026-07-15T23:46:58.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Zoetis announces European Commission marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine that protects chickens against Newcastle disease and Marek's disease with a single dose. The vaccine can be administered in ovo or by injection at hatch.
    Difference
    0.9%
    Check dated 2026-07-08T12:14:22.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    New press release entry added with the headline 'Zoetis to Host Webcast and Conference Call on Second Quarter 2026 Financial Results' dated June 25, 2026. It announces a webcast on August 6, 2026, including speakers, access details, and pre-registration for investors.
    Difference
    1.0%
    Check dated 2026-07-01T10:20:00.000Z thumbnail image

Stay in the know with updates to Zoetis Press Releases

Enter your email address, and we'll notify you when there's something new on the Zoetis Press Releases page.